By Professor Alison Ritter

Journal articles

Tucker TK; Ritter AJ; Maher C; Jackson H, 2004, 'Naltrexone maintenance for heroin dependence: Uptake, attrition and retention', Drug and Alcohol Review, 23, pp. 299 - 309, http://dx.doi.org/10.1080/09595230412331289464

Lintzeris N; Ritter A; Panjari M; Clark N; Kutin J; Bammer G, 2004, 'Implementing Buprenorphine Treatment in Community Settings in Australia: Experiences from the Buprenorphine Implementation Trial', American Journal on Addictions, 13, http://dx.doi.org/10.1080/10550490490440799

Caplehorn J; Ritter A, 2004, 'Comments on Ritter et al.'s report of a comparative trial of laam and methadone maintenance [1] (multiple letters)', Addiction, 99, pp. 509 - 510, http://dx.doi.org/10.1111/j.1360-0443.2004.00682.x

RITTER A, 2004, 'LAAM vs. methadone: a response to Caplehorn', Addiction, 99, pp. 510 - 511, http://dx.doi.org/10.1111/j.1360-0443.2004.00695.x

Tucker T; Fry C; Lintzeris N; Baldwin S; Ritter A; Donath S; Whelan G, 2004, 'Randomized controlled trial of a brief behavioural intervention forreducing hepatitis C virus risk practices among injecting drug users', Addiction, 99, pp. 1157 - 1166

Digiusto EA; Shakeshaft AP; Ritter A; O Brien SM; Mattick RP, 2004, 'Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD)', Addiction, 99, pp. 450 - 460

Ritter AJ; Lintzeris N; Clark N; Kutin JJ; Bammer G; Panjari M, 2003, 'A randomized trial comparing levo-alpha acetylmethadol with methadone maintenance for patients in primary care settings in Australia', Addiction, 98, pp. 1605 - 1613, http://dx.doi.org/10.1046/j.1360-0443.2003.00529.x

Ritter AJ; Fry CL; Swan A, 2003, 'The ethics of reimbursing injecting drug users for public health research interviews: What price are we prepared to pay?', International Journal of Drug Policy, 14, pp. 1 - 3, http://dx.doi.org/10.1016/S0955-3959(02)00094-4

Breen CL; Harris S; Lintzeris N; Mattick RP; Hawken L; Bell JR; Ritter A; Lenne M; Mendoza E, 2003, 'Cessation of methadone maintenance treatment using uprenorphine: transfer from methadone to buprenorphine and subsequent buprenorphine reductions', Drug and Alcohol Dependence, 71, pp. 49 - 55

Lintzeris N; Dunlop A; Muhleisen P; Ritter A, 2002, 'Training primary health care professionals to prvide Buprenorphine and LAAM treatment', Substance Abuse, 23, pp. 245 - 254, http://dx.doi.org/10.1080/08897070209511497

Ritter A; Bowden S; Murray T; Ross P; Greeley J; Pead J, 2002, 'The influence of the therapeutic relationship in treatment for alcohol dependency', Drug and Alcohol Review, 21, pp. 261 - 268, http://dx.doi.org/10.1080/0959523021000002723

Ritter AJ, 2002, 'Naltrexone in the treatment of heroin dependence: Relationship with depression and risk of overdose', Australian and New Zealand Journal of Psychiatry, 36, pp. 224 - 228, http://dx.doi.org/10.1046/j.1440-1614.2002.01012.x

Wodak AD; Ritter AJ; Watson CRR; Hall WD; Mattick RP; Kimber J, 2002, 'Separating politics and scientific research on heroin prescription (multiple letters)', Medical Journal of Australia, 176, pp. 449 - 450, http://dx.doi.org/10.5694/j.1326-5377.2002.tb04510.x

Clark N; Lintzeris N; Gijsbers A; Whelan G; Dunlop A; Ritter A; Ling W, 2002, 'LAAM maintenance vs methadone maintenance for heroin dependence.', Cochrane database of systematic reviews (Online)

Lintzeris N; Ritter A; Dunlop A; Muhleisen P, 2002, '', Substance Abuse, 23, pp. 245 - 254, http://dx.doi.org/10.1023/a:1021102301285

Dunlop A; Higgs P; Jordens J; Ritter A; Bammer G; Whelan G; Maher L; Higgs P, 2002, 'Vietnamese-Australian heroin users; Ambulatory withdrawal and 24-month follow-up', Addiction Biology, 7, pp. 335 - 335

Bowden SC; Ritter AJ; Carstairs JR; Shores EA; Pead J; Greeley JD; Whelan G; Long CM; Clifford CC, 2001, 'Factorial invariance for combined Wechsler Adult intelligence Scale-Revised and Wechsler Memory Scale-Revised scores in a sample of clients with alcohol dependency', Clinical Neuropsychologist, 15, pp. 69 - 80, http://dx.doi.org/10.1076/clin.15.1.69.1910

Ritter A, 2001, 'Buprenorphine for the treatment of heroin dependence', DRUG AND ALCOHOL REVIEW, 20, pp. 5 - 7, http://dx.doi.org/10.1080/0959523020035240

Lenne M; Lintzeris N; Breen CL; Harris S; Hawken L; Mattick RP; Ritter A, 2001, 'Withdrawal from methadone maintenance treatment: prognosis and participant perspectives', Australian and New Zealand Journal of Public Health, pp. 121 - 125

Tucker TK; Ritter AJ, 2000, 'Naltrexone in the treatment of heroin dependence: A literature review', Drug and Alcohol Review, 19, pp. 73 - 82, http://dx.doi.org/10.1080/09595230096174

Lintzeris N; Lenné M; Ritter A, 1999, 'Methadone injecting in Australia: A tale of two cities', Addiction, 94, pp. 1175 - 1178, http://dx.doi.org/10.1046/j.1360-0443.1999.94811757.x

Ritter A; Lang E; Kutin J; King T; Dietze P, 1999, 'News and Views', Drug and Alcohol Review, 18, pp. 117 - 122, http://dx.doi.org/10.1080/09595239996842

Bowden SC; Fowler KS; Bell RC; Whelan G; Clifford CC; Ritter AJ; Long CM, 1998, 'The reliability and internal validity of the Wisconsin Card Sorting Test', Neuropsychological Rehabilitation, 8, pp. 243 - 254, http://dx.doi.org/10.1080/713755573

Bowden SC; Dodds B; Whelan G; Long C; Dudgeon P; Ritter A; Clifford C, 1997, 'Confirmatory factor analysis of the Wechsler Memory Scale-Revised in a sample of clients with alcohol dependency', Journal of Clinical and Experimental Neuropsychology, 19, pp. 755 - 762, http://dx.doi.org/10.1080/01688639708403757

Bowden SC; Benedikt R; Ritter AJ, 1992, 'Delayed matching to sample and concurrent learning in nonamnesic humans with alcohol dependence', Neuropsychologia, 30, pp. 427 - 435, http://dx.doi.org/10.1016/0028-3932(92)90090-9

RITTER AJ; COLE MJ, 1992, 'Men's issues: gender role conflict and substance abuse', Drug and Alcohol Review, 11, pp. 163 - 167, http://dx.doi.org/10.1080/09595239200185641

Bond NW; Homewood J; Bowden SC; Ritter AJ; Wodak A, 1991, 'Thiamine in our bread and wine [7]', Medical Journal of Australia, 154, pp. 780 - 781, http://dx.doi.org/10.5694/j.1326-5377.1991.tb121339.x

Conference Papers

Cunninham E; van de Ven K; Ritter A, 2022, 'Capacity building for outcome evaluations: Lessons learned using participatory methods to develop a routine data collection protocol within two Aboriginal and Torres Strait Islander alcohol and other drug residential rehabilitation services in Queensland', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S50 - S51, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700088&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Shukla N; Cao VL; Phuong VH; Shanahan M; Ritter A; Perez P, 2016, 'Individual-Level Simulation Model For Cost Benefit Analysis In Healthcare', in ECMS 2016 Proceedings edited by Thorsten Claus, Frank Herrmann, Michael Manitz, Oliver Rose, ECMS, presented at 30th Conference on Modelling and Simulation, http://dx.doi.org/10.7148/2016-0137

Berends L; Ritter A; Chalmers J, 2014, 'Government communication during alcohol and other drug sector reform', Turin, Italy, presented at 40th Annual Symposium of the Kettil Bruun Society, Turin, Italy, 09 June 2014 - 13 June 2014

Shukla N; Hoang V; Shahanan M; Ritter A; Cao VL; Perez P, 2014, 'A lifetime individual sampling model (ISM) for heroin use and treatment evaluation in Australia', in 3rd International Workshop on Innovative Simulation for Health Care, IWISH 2014, pp. 6 - 13

Perez P; Dray A; Ritter A; Dietze P; Moore T; Mazerolle L, 2006, 'SimDrug: Exploring the complexity of illicit drug markets', in 50th Annual Meeting of the International Society for the Systems Sciences 2006, ISSS 2006, pp. 175 - 197

Ritter A, 2004, 'The 15th International Conference on the Reduction of Drug Related Harm, Melbourne, Australia, 20-24th April 2004', in International Journal of Drug Policy, pp. 311 - 314, http://dx.doi.org/10.1016/j.drugpo.2004.05.003

Ritter AJ, 2004, 'Drug dependence: Evidence-base for treatment and translating research into practice', in CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, BLACKWELL PUBLISHING ASIA, AUSTRALIA, Brisbane, pp. A218 - A218, presented at 8th World Congress of Clinical Pharmacology and Therapeutics, AUSTRALIA, Brisbane, 01 August 2004 - 06 August 2004, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000225490400029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Posters

O'Reilly M; Hughes CE; Bright D; Ritter A, 2017, 'Understanding how high-level ecstasy traffickers in Australia adapt to changes in their drug supply', Adelaide, presented at 9th Annual Iliicit Networks Workshop, Adelaide, 11 December 2017 - 12 December 2017

Conference Presentations

Kelaita P; McLauchlan L; Kowalski M; Ritter A, 2023, 'Post-retirement enlightenment syndrome: Understanding the conditions of support for drug policy reform', presented at Australian Social Policy Conference, ANU, Canberra, 11 September 2023 - 13 September 2023

Lancaster K; Ritter A; valentine K; Rhodes T, 2018, '“A more accurate understanding of drug use”: A critical analysis of wastewater analysis technology for drug policy', presented at International Society for the Study of Drug Policy Conference, Vancouver, Canada, 16 May 2018 - 18 May 2018

Lancaster K; valentine K; Ritter A, 2017, 'Wastewater analysis: a dangerous consumption?', presented at Dangerous Consumptions Colloquium, Canberra, 04 December 2017 - 05 December 2017

Conference Abstracts

Stirling R; Nathan S; Ritter A, 2022, 'Reaching consensus on the most important measures of performance for New South Wales non-government alcohol and other drugs treatment services', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S130 - S130, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700224&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Stirling R; Ritter A; Nathan S, 2021, '"WE HAVE TO ACCEPT THAT NOT EVERYBODY'S GONNA HAVE AN ABSTINENCE OUTCOME": EXPLORING THE VIEWS OF FUNDERS, TREATMENT PROVIDERS AND SERVICE USERS ON PERFORMANCE MEASUREMENT', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 40, pp. S136 - S137, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200332&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ritter A; van de Ven K; Vuong T; Chalmers J; Dobbins T; Livingston M; Berends L, 2021, 'THE ASSOCIATION BETWEEN TREATMENT COMMISSIONING MECHANISMS AND ENSUING WORKFORCE CHARACTERISTICS, AND ALCOHOL AND OTHER DRUG TREATMENT OUTCOMES', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 40, pp. S125 - S125, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200306&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Nielsen S; Picco L; Kowalski M; Wood P; Bruno R; Ritter A, 2019, 'IMPLEMENTING ROUTINE OPIOID OUTCOME MONITORING IN COMMUNITY PHARMACIES: FINDINGS FROM A PILOT FEASIBILITY STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S78 - S79, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100197&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Smith JA; Whetton S; D'Abbs P; Adamson E; Clifford S; Wallace T; Stephens D-M; Van de Ven K; Mellor R; Stevens M; Dyall D; Christie B; Ritter A; Thorn M, 2019, 'SYMPOSIUM: ALCOHOL HARM MINIMISATION IN THE NORTHERN TERRITORY: BUILDING CONTEXTUAL EVIDENCE TO INFORM POLICY AND PRACTICE CHANGE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S16 - S16, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494890100040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Whetton S; Tait RJ; Cartwright K; Ferrante A; Gray D; Kaye S; McKetin R; Pidd K; Ritter A; Roche A; Allsop S, 2018, 'HARMS TO RESIDENT ADULTS AND ADULT FAMILY MEMBERS OF A PERSON DEPENDENT ON METHAMPHETAMINE: COUNTING THE COSTS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S74 - S75, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449495000183&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tait RJ; Allsop S; Cartwright K; Ferrante A; Gray D; Kaye S; McKetin R; Pidd K; Ritter A; Roche A; Whetton S; Shanahan M, 2018, 'REMEDIATION AND PROPERTY VALUES: THE COSTS OF CLANDESTINE METHAMPHETAMINE MANUFACTURING IN AUSTRALIA', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S69 - S70, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449495000173&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Barratt MJ; Bruno R; Ezard N; Ritter A, 2016, 'THE FEASIBILITY OF USER-SUBMITTED DRUG OR PILL TESTING SERVICES IN AUSTRALIA', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 25 - 25

Lancaster K; Duke K; Ritter A, 2014, 'EXAMINING THE CONSTRUCTION AND REPRESENTATION OF 'RECOVERY' IN UNITED KINGDOM AND AUSTRALIAN DRUG POLICY DISCUSSIONS', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 33, pp. 38 - 38, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800110&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ritter A, 2014, 'JAMES RANKIN ORATION: THE CHALLENGES OF POLICY RESEARCH THAT AIMS TO MAKE A DIFFERENCE', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 33, pp. 1 - 1, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Scott N; Caulkins JP; Dietze P; Ritter A, 2014, 'PATTERNS OF DRUG PREFERENCE AND USE AMONG PEOPLE WHO INJECT DRUGS IN VICTORIA', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, Vol. 33, pp. 56 - 56, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344914800161&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Reports

Ritter A; Barrett L; Keelin O; Wilkinson C, 2023, Lessons learnt from alcohol and tobacco for cannabis regulation, Swiss Federal Office of Public Health, Switzerland, http://dx.doi.org/10.26190/unsworks/28708, https://www.bag.admin.ch/dam/bag/de/dokumente/npp/forschungsberichte/forschungsberichte-cannabis/lessons-for-cannabis-regulation.pdf.download.pdf/Schlussbericht_Lessons_Cannabis_Regulation.pdf

Back to profile page